Nursing care
End-Stage Renal Disease nursing care: what to assess and what to do first
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
End-stage renal disease nursing care is defined by a GFR under 15 and built around protecting the dialysis access: no blood pressures, no venepuncture, and no IVs on that arm, with a thrill checked every shift. Fluid balance, potassium, and cardiac status drive the rest of the plan.
The pathophysiology in one pass
End-stage renal disease is defined by a glomerular filtration rate under 15 mL/min/1.73m², the point at which the kidneys can no longer clear waste products or regulate fluid, electrolytes, and acid-base balance well enough to sustain life without dialysis or transplant. Nephron loss is irreversible by this stage; the damage accumulated through years of diabetes, hypertension, glomerulonephritis, or polycystic kidney disease has passed the point where compensation is possible.
The downstream effects touch nearly every system. Erythropoietin production falls, driving a normocytic anemia. Activated vitamin D drops while phosphate rises, disturbing calcium balance and bone metabolism. Sodium and water retention drive hypertension and fluid overload, and the kidneys lose their ability to excrete potassium and hydrogen ions, producing hyperkalemia and metabolic acidosis. Uremic toxins accumulate and affect the brain, the gut, the skin, and platelet function, which is why ESRD is a whole-body disease managed by a nurse, not a kidney problem managed in isolation.
Assessment findings that matter
Fluid status assessment is daily and non-negotiable: daily weights at the same time on the same scale, intake and output, lung sounds for crackles, jugular venous distension, and peripheral or sacral edema. A weight gain of more than a kilogram or two between dialysis sessions signals fluid accumulation that needs addressing before the next treatment.
Cardiovascular findings deserve particular attention because cardiovascular disease is the leading cause of death in ESRD, not kidney failure itself. Watch for hypertension, arrhythmias linked to potassium shifts, and pericardial friction rub, which can indicate uremic pericarditis, a serious complication requiring urgent dialysis. Skin assessment picks up pallor from anemia, bruising from platelet dysfunction, and uremic frost in advanced untreated cases. Neurological status, level of consciousness, asterixis, and reported itching all track uremic toxin burden and should be reassessed regularly, not just on admission.
What the exam asks about this
NCLEX items on ESRD lean heavily on access protection because it is the detail most likely to be tested and most consequential to get wrong. Expect a question describing an AV fistula or graft and asking which action is contraindicated; the correct response rules out blood pressure measurement, venepuncture, and IV insertion on that limb every time, no exceptions for convenience.
The second recurring theme is potassium. Questions often present an ECG change, peaked T waves, or a lab value and ask for the priority action, which is usually to hold potassium-containing foods or medications and notify the provider, since hyperkalemia in ESRD can progress to lethal arrhythmia quickly. A third pattern tests prioritization across ESRD's many findings at once, asking which assessment or intervention comes first among several correct-sounding options; the access and cardiac findings generally outrank comfort measures like itching or fatigue in that ranking.
Nursing interventions in priority order
Protect the access first. Check for a thrill by palpation and a bruit by auscultation every shift on an AV fistula or graft; a diminished or absent thrill signals possible clotting and needs immediate provider notification. No blood pressures, no venepuncture, and no IV insertion on that arm, and post a sign at the bedside so the restriction is visible to every team member who touches the patient.
Manage fluid volume through the prescribed restriction, spacing intake across the day and around medication administration to help patients tolerate the limit. Monitor for and respond to hyperkalemia, since it is the most immediately dangerous electrolyte disturbance in ESRD; report peaked T waves, widened QRS, or a rising potassium value without delay. Support skin integrity given uremic pruritus and fragile, easily bruised skin, and monitor for signs of infection at any access site, since immune function is blunted in uremia and infection can progress silently.
Medications and monitoring
Erythropoiesis-stimulating agents, epoetin alfa or darbepoetin, treat the anemia of chronic kidney disease and require monitoring of hemoglobin to keep it in target range without overcorrecting, which raises cardiovascular risk. Phosphate binders, calcium acetate, sevelamer, or lanthanum, must be given with meals, not on an empty stomach, since they work by binding dietary phosphate in the gut.
Active vitamin D analogues and calcimimetics manage secondary hyperparathyroidism from disturbed calcium-phosphate balance. Many standard medications need renal dosing adjustment or complete avoidance, magnesium-containing antacids and NSAIDs among them, so every new order should be checked against renal function. Iron supplementation, oral or IV, often accompanies ESA therapy since adequate iron stores are needed for the drug to work. Monitor potassium, calcium, phosphate, and bicarbonate with every lab draw, and track dialysis adequacy markers when the patient is on treatment.
When to escalate
Escalate immediately for a diminished or absent thrill or bruit over an access, since a clotted fistula or graft threatens the patient's lifeline for dialysis and often needs urgent intervention to salvage. Escalate for ECG changes consistent with hyperkalemia, peaked T waves, widened QRS, or any new dysrhythmia, and for a potassium value that has risen sharply from baseline.
Report pericardial friction rub or chest pain suggestive of uremic pericarditis promptly, as it can progress to tamponade and typically prompts urgent dialysis. Significant fluid overload with respiratory distress, new confusion or a falling level of consciousness suggesting worsening uremic encephalopathy, and uncontrolled bleeding from platelet dysfunction all warrant immediate provider notification rather than routine reporting at the next round.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our renal and genitourinary practice questions are the closest set to what this page covers.
Common questions
What GFR defines end-stage renal disease?
A GFR under 15 mL/min/1.73m² defines end-stage renal disease, the point at which dialysis or transplant is typically needed to sustain life. Above that threshold, patients are classified in earlier stages of chronic kidney disease with different management priorities.
Why can't you take a blood pressure on the arm with a fistula?
Cuff compression can occlude flow through the fistula and precipitate clotting, which can destroy the access entirely. The same reasoning rules out venepuncture and IV insertion on that limb, and the restriction should be clearly documented and signed at the bedside.
How do you check if a dialysis access is still working?
Palpate for a thrill, a soft continuous vibration, and auscultate for a bruit, a whooshing sound, over the access every shift. A diminished or absent thrill or bruit suggests possible thrombosis and needs immediate provider notification.
Why do phosphate binders need to be taken with food?
Phosphate binders work by binding dietary phosphate in the gut before it's absorbed, so they're only effective when taken with meals. Given on an empty stomach, they have nothing to bind and provide no benefit.
What's the most dangerous electrolyte problem in ESRD?
Hyperkalemia, because the kidneys can no longer excrete potassium and even modest dietary intake can push levels into a range that triggers lethal arrhythmias. Peaked T waves on ECG are an early warning sign that should prompt immediate reporting.